Literature DB >> 25700602

Evidence about inotropes: when is enough, enough?

Anthony C Gordon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25700602     DOI： 10.1007/s00134-015-3698-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  15 in total

1.  Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality.

Authors:  John H Boyd; Jason Forbes; Taka-aki Nakada; Keith R Walley; James A Russell
Journal:  Crit Care Med       Date:  2011-02       Impact factor: 7.598

2.  Comparison of dopamine and norepinephrine in the treatment of shock.

Authors:  Daniel De Backer; Patrick Biston; Jacques Devriendt; Christian Madl; Didier Chochrad; Cesar Aldecoa; Alexandre Brasseur; Pierre Defrance; Philippe Gottignies; Jean-Louis Vincent
Journal:  N Engl J Med       Date:  2010-03-04       Impact factor: 91.245

3.  Elevation of systemic oxygen delivery in the treatment of critically ill patients.

Authors:  M A Hayes; A C Timmins; E H Yau; M Palazzo; C J Hinds; D Watson
Journal:  N Engl J Med       Date:  1994-06-16       Impact factor: 91.245

4.  Sequential cardiorespiratory patterns associated with outcome in septic shock.

Authors:  E Abraham; R D Bland; J C Cobo; W C Shoemaker
Journal:  Chest       Date:  1984-01       Impact factor: 9.410

5.  Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trial.

Authors:  Djillali Annane; Philippe Vignon; Alain Renault; Pierre-Edouard Bollaert; Claire Charpentier; Claude Martin; Gilles Troché; Jean-Damien Ricard; Gérard Nitenberg; Laurent Papazian; Elie Azoulay; Eric Bellissant
Journal:  Lancet       Date:  2007-08-25       Impact factor: 79.321

6.  Effect of heart rate control with esmolol on hemodynamic and clinical outcomes in patients with septic shock: a randomized clinical trial.

Authors:  Andrea Morelli; Christian Ertmer; Martin Westphal; Sebastian Rehberg; Tim Kampmeier; Sandra Ligges; Alessandra Orecchioni; Annalia D'Egidio; Fiorella D'Ippoliti; Cristina Raffone; Mario Venditti; Fabio Guarracino; Massimo Girardis; Luigi Tritapepe; Paolo Pietropaoli; Alexander Mebazaa; Mervyn Singer
Journal:  JAMA       Date:  2013-10-23       Impact factor: 56.272

7.  Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock, 2012.

Authors:  R P Dellinger; Mitchell M Levy; Andrew Rhodes; Djillali Annane; Herwig Gerlach; Steven M Opal; Jonathan E Sevransky; Charles L Sprung; Ivor S Douglas; Roman Jaeschke; Tiffany M Osborn; Mark E Nunnally; Sean R Townsend; Konrad Reinhart; Ruth M Kleinpell; Derek C Angus; Clifford S Deutschman; Flavia R Machado; Gordon D Rubenfeld; Steven Webb; Richard J Beale; Jean-Louis Vincent; Rui Moreno
Journal:  Intensive Care Med       Date:  2013-01-30       Impact factor: 17.440

8.  Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH).

Authors:  Anthony C Gordon; Alexina J Mason; Gavin D Perkins; Deborah Ashby; Stephen J Brett
Journal:  BMJ Open       Date:  2014-07-03       Impact factor: 2.692

9.  Association of arterial blood pressure and vasopressor load with septic shock mortality: a post hoc analysis of a multicenter trial.

Authors:  Martin W Dünser; Esko Ruokonen; Ville Pettilä; Hanno Ulmer; Christian Torgersen; Christian A Schmittinger; Stephan Jakob; Jukka Takala
Journal:  Crit Care       Date:  2009-11-16       Impact factor: 9.097

Review 10.  Levosimendan: current data, clinical use and future development.

Authors:  M S Nieminen; S Fruhwald; L M A Heunks; P K Suominen; A C Gordon; M Kivikko; P Pollesello
Journal:  Heart Lung Vessel       Date:  2013
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.